{rfName}

Indexed in

License and use

Icono OpenAccess

Altmetrics

Analysis of institutional authors

Ferrés ACorresponding AuthorDi Somma AAuthorRoldán PAuthorPedrosa LAuthorDiao DAuthorPineda EAuthorEnseñat JAuthorGonzález-Sánchez JjAuthor

Share

December 26, 2022
Publications
>
Article

Photodynamic therapy in glioblastoma: Detection of intraoperative inadvertent 5-ALA mediated photodynamic therapeutical effect after gross total resection

Publicated to:Frontiers In Oncology. 12 1080685- - 2022-12-02 12(), DOI: 10.3389/fonc.2022.1080685

Authors: Ferres, Abel; Di Somma, Alberto; Mosteiro, Alejandra; Eduardo Topczewski, Thomaz; Roldan, Pedro; Pedrosa, Leire; Diao, Dioulde; Pineda, Estela; Sierra, Angels; Ensenat, Joaquim; Gonzalez-Sanchez, Jose Juan

Affiliations

August Pi & Sunyer Biomed Res Inst IDIBAPS, Fac Med, Dept Biomed, Barcelona, Spain - Author
Department of Biomedicine, Faculty of Medicine, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. - Author
Department of Medicine and Life Sciences, Facultad de Ciencias de la Salud y de la Vida, Universidad Pompeu Fabra, Barcelona, Spain. - Author
Department of Neurosurgery, Clínic Institute of Neurosciences, Hospital Clínic of Barcelona, Barcelona, Spain. - Author
Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. - Author
Hosp Clin Barcelona, Clin Inst Hematol & Ontol Dis, Serv Oncol Med, Barcelona, Spain - Author
Hosp Clin Barcelona, Clin Inst Neurosci, Dept Neurosurg, Barcelona, Spain - Author
Servicio de Oncología Médica, Clinical Institute of Hematological and Oncological Diseases, Hospital Clinic of Barcelona, Barcelona, Spain. - Author
Univ Barcelona, Fac Med & Hlth Sci, Barcelona, Spain - Author
Univ Pompeu Fabra, Dept Med & Life Sci, Fac Ciencias Salud & Vida, Barcelona, Spain - Author
See more

Abstract

Glioblastoma (GBM) remains the most frequent and lethal primary brain tumor in adults, despite advancements in surgical resection techniques and adjuvant chemo- and radiotherapy. The most frequent recurrence pattern (75-90%) occurs in the form of continuous growth from the border of the surgical cavity, thus emphasizing the need for locoregional tumor control. Fluorescence-guided surgical resection using 5-ALA has been widely implemented in surgical protocols for such tumors. Recent literature also highlights the applicability of 5-ALA-mediated photodynamic therapy to obtain locoregional tumor control further. This study aims to identify if 5-ALA mediated photodynamic therapeutic effect after gross total glioblastoma resection has inadvertently occurred due to the exposition of protoporphyrin IX charged peripheral tumoral cells to operative room light sources.Of 146 patients who were intervened from glioblastoma between 2015 and 2020, 33 were included in the present study. Strict gross total resection (without supralocal resection) had been accomplished, and adjuvant chemoradiotherapy protocol was administered. Two comparison groups were created regarding the location of the recurrence (group A: up to 1 centimeter from the surgical cavity, and group B: beyond 1 centimeter from the surgical cavity). The cutoff point was determined to be 1 centimeter because of the visible light penetrance to the normal brain tissue.In univariate analysis, both groups only differed regarding 5-ALA administration, which was significantly related to a minor relative risk of presenting the recurrence within the first centimeter from the surgical cavity (Relative Risk = 0,655 (95% CI 0,442-0,970), p-value=0,046). Results obtained in univariate analysis were corroborated posteriorly in multivariate analysis (RR=0,730 (95% CI 0,340-0,980), p=0,017).In the present study, a probable inadvertent 5-ALA photodynamic therapeutical effect has been detected in vivo. This finding widely opens the door for further research on this promising theragnostic tool.Copyright © 2022 Ferrés, Di Somma, Mosteiro, Topczewski, Roldán, Pedrosa, Diao, Pineda, Sierra, Enseñat and González-Sánchez.

Keywords

5-aminolevulinic acidadjuvant temozolomideconcomitantdiffuse gliomafluorescenceglioblastomalocorregional adjuvant therapymultiformeneurosurgical oncologypatternsphase-iiiradiotherapytumors5-aminolevulinic acidAdjuvant chemoradiotherapyAdultAminolevulinic acidAphasiaArticleBehavior changeBrain tissueCentral nervous systemControlled studyFacial nerve paralysisFemaleGlioblastomaHeadacheHemiparesisHumanInterventional magnetic resonance imagingLength of stayLight exposureLocorregional adjuvant therapyMaleMalignant gliomaMutismNeuromonitoringNeurosurgical oncologyOperation durationOrthopedic surgeryPenetrancePhotodynamic therapyPreoperative evaluationProtoporphyrinRetrospective studySeizureTumor volumeUnivariate analysis

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Frontiers In Oncology due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 85/241, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Oncology. Notably, the journal is positioned en el Cuartil Q2 para la agencia Scopus (SJR) en la categoría Oncology.

From a relative perspective, and based on the normalized impact indicator calculated from the Field Citation Ratio (FCR) of the Dimensions source, it yields a value of: 2.15, which indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: Dimensions Jul 2025)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-05, the following number of citations:

  • WoS: 3
  • Scopus: 2
  • Europe PMC: 1

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-05:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 17.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 17 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 0.5.
  • The number of mentions on the social network X (formerly Twitter): 1 (Altmetric).

It is essential to present evidence supporting full alignment with institutional principles and guidelines on Open Science and the Conservation and Dissemination of Intellectual Heritage. A clear example of this is:

  • The work has been submitted to a journal whose editorial policy allows open Open Access publication.

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: First Author (Ferres Coy, Albert) and Last Author (González Sanchez, Josep Juan).

the author responsible for correspondence tasks has been Ferres Coy, Albert.